273 related articles for article (PubMed ID: 25292283)
1. The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice.
Meneses C; Morales MG; Abrigo J; Simon F; Brandan E; Cabello-Verrugio C
Pflugers Arch; 2015 Sep; 467(9):1975-84. PubMed ID: 25292283
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C
Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1-7) through a p38 MAPK-dependent mechanism.
Morales MG; Olguín H; Di Capua G; Brandan E; Simon F; Cabello-Verrugio C
Clin Sci (Lond); 2015 Sep; 129(6):461-76. PubMed ID: 25989282
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation.
Ábrigo J; Simon F; Cabrera D; Cabello-Verrugio C
Cell Physiol Biochem; 2016; 40(1-2):27-38. PubMed ID: 27842312
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle wasting: new role of nonclassical renin-angiotensin system.
Cabello-Verrugio C; Rivera JC; Garcia D
Curr Opin Clin Nutr Metab Care; 2017 May; 20(3):158-163. PubMed ID: 28207424
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Mas receptor is upregulated in skeletal muscle wasting.
Morales MG; Abrigo J; Meneses C; Cisternas F; Simon F; Cabello-Verrugio C
Histochem Cell Biol; 2015 Feb; 143(2):131-41. PubMed ID: 25208653
[TBL] [Abstract][Full Text] [Related]
8. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy.
Rezk BM; Yoshida T; Semprun-Prieto L; Higashi Y; Sukhanov S; Delafontaine P
PLoS One; 2012; 7(1):e30276. PubMed ID: 22276172
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) Prevents Lipopolysaccharide-Induced Autophagy via the Mas Receptor in Skeletal Muscle.
Rivera JC; Abrigo J; Tacchi F; Simon F; Brandan E; Santos RA; Bader M; Chiong M; Cabello-Verrugio C
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302427
[TBL] [Abstract][Full Text] [Related]
11. The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.
Morales MG; Abrigo J; Meneses C; Simon F; Cisternas F; Rivera JC; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2014 Aug; 127(4):251-64. PubMed ID: 24588264
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of Angiotensin 1-7 on Sarcopenia Induced by Chronic Liver Disease in Mice.
Aguirre F; Abrigo J; Gonzalez F; Gonzalez A; Simon F; Cabello-Verrugio C
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485991
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin (1-7) Decreases Myostatin-Induced NF-κB Signaling and Skeletal Muscle Atrophy.
Aravena J; Abrigo J; Gonzalez F; Aguirre F; Gonzalez A; Simon F; Cabello-Verrugio C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050585
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
16. High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis.
Abrigo J; Rivera JC; Aravena J; Cabrera D; Simon F; Ezquer F; Ezquer M; Cabello-Verrugio C
Oxid Med Cell Longev; 2016; 2016():9047821. PubMed ID: 27579157
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects the function of pancreatic β cells by improving the function of islet microvascular endothelial cells.
Lu CL; Wang Y; Yuan L; Li Y; Li XY
Int J Mol Med; 2014 Nov; 34(5):1293-300. PubMed ID: 25175177
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle.
Kadoguchi T; Kinugawa S; Takada S; Fukushima A; Furihata T; Homma T; Masaki Y; Mizushima W; Nishikawa M; Takahashi M; Yokota T; Matsushima S; Okita K; Tsutsui H
Exp Physiol; 2015 Mar; 100(3):312-22. PubMed ID: 25580531
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.
Muñoz MC; Burghi V; Miquet JG; Giani JF; Banegas RD; Toblli JE; Fang Y; Wang F; Bartke A; Dominici FP
J Endocrinol; 2014 May; 221(2):215-27. PubMed ID: 24756097
[TBL] [Abstract][Full Text] [Related]
20. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
